RESUMEN
Scientists have been working to replace graphite, the state-of-art anode material, to improve battery performances. In this sense, transitional metals and their oxides become attractive due to their capacities, widespread availabilities, and environmental benignity. In this paper, first in literature, a progressive study has been followed to evaluate the possible uses of pristine, partially oxidized and reduced Mo oxide films (with glucose droplets on top of the oxide layer gives the hybride and the film without glucose droplets on top of the oxide film gives merely reduced Mo oxide film) as anodes in lithium ion batteries. Unlike to conventional studies, herein the oxidation of molybdenum (Mo) atoms is restricted with the surface atoms to benefit the advantages of metallic Mo atoms at the electrode/current collector interface. These Mo atoms which are inactive versus Li and insoluble in copper are expected to create conductive pathway in the oxide (or hybride) films as well as minimize volume changes in cycling. Knowing that carbonaceous materials have been used as efficient additives to improve the electrochemical performance of electrodes, the best performance is achieved when the hybrid molydenbum oxide (C film on top of the reduced molybdenum oxide film as a result of the reduction of the glucose droplet) sample is cycled between 0.005-3.0 V versus Li/Li+.
RESUMEN
BACKGROUND: Adolescence represents a transitional period which is marked by physical, social and psychological changes. Changes in body shape and physical activity especially alter and shape the psychological well-being of adolescents. AIM: The purpose of this study was to determine the role of physical activity level, body mass index and maturity status in body-related perception and self-esteem of 11-18 years old adolescents. SUBJECTS AND METHODS: A total of 1012 adolescents participated in this study. The "Social Physique Anxiety Scale", "Body Image Satisfaction Scale", "Physical Self-Perception Profile for Children" and "Rosenberg Self-Esteem Inventory" were administered. Physical activity level and body mass index were assessed using the "Physical Activity Questionnaire" and "Bioelectrical Impedance Analyzer", respectively. RESULTS: Regression analysis indicated that body mass index was the only predictor of perceived body attractiveness, social physique anxiety, body image satisfaction and self-esteem for female adolescents. For male adolescents, both physical activity and body mass index were correlated with perceived body attractiveness and social physique anxiety. Pubertal status were not correlated with self-esteem and body-related perceptions for both males and females adolescents. CONCLUSION: In summary, body mass index and physical activity plays an important role in body-related perceptions and self-esteem of adolescents.
Asunto(s)
Imagen Corporal , Índice de Masa Corporal , Actividad Motora , Autoimagen , Maduración Sexual , Adolescente , Niño , Estudios Transversales , Femenino , Humanos , Masculino , Encuestas y Cuestionarios , TurquíaRESUMEN
OBJECTIVE: In this study, we evaluated clinical and epidemiologic features of our giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) patients. METHODS: We retrospectively recorded down the general features of patients with GCA and PMR diagnosed at our center within the last 6 years. The incidence rates per 100000 aged > or =50 were calculated. In addition, we reported the frequencies of GCA/PMR in our previous epidemiologic study. RESULTS: Nineteen patients were diagnosed with GCA (10F, 9M) and 53 with isolated PMR (39F, 14M). The annual incidence for GCA in subjects > or =50 years old was 1.13/100000, and for PMR it was 3.15/100000. The incidence of GCA and PMR in females were, respectively, 1.14/100000 and 4.48/100000. In males, the incidences of GCA and PMR were, respectively, calculated as 1.1/100000 and 1.72/100000. In our population-based study, the prevalences of GCA and PMR (> or =50 ages) were estimated as 20/100000. Fourteen (73.7%) GCA patients had symptoms of PMR. Two patients had developed unilateral and one patient bilateral permanent visual loss. Initial ESR was lower than 40 mm/hr in one GCA patient (5.3%) and in 6 PMR patients (11.3%). The median duration of follow-up was 16 months in GCA; and 8 months in PMR patients. One patient with PMR and another patient with GCA had lung cancer. One PMR patient had myelodysplastic syndrome. During follow-up, 4 patients with GCA died. CONCLUSION: We detected a lower frequency of GCA/PMR in our center in northwestern Turkey than in Scandinavian and southern European countries.
Asunto(s)
Arteritis de Células Gigantes/epidemiología , Polimialgia Reumática/epidemiología , Distribución por Edad , Anciano , Anciano de 80 o más Años , Sedimentación Sanguínea , Proteína C-Reactiva/análisis , Femenino , Estudios de Seguimiento , Arteritis de Células Gigantes/sangre , Arteritis de Células Gigantes/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Polimialgia Reumática/sangre , Polimialgia Reumática/diagnóstico , Prevalencia , Estudios Retrospectivos , Turquía/epidemiologíaRESUMEN
Coronary artery aneurysm (CAA) is a relatively rare disease that may cause angina, myocardial infarction, sudden death due to thrombosis, embolisation, or rupture. This report describes the case of a man aged 65 years old who had an anterior myocardial infarction due to left anterior descending artery (LAD) aneurysm. We attempted early percutaneous transluminal coronary angioplasty (PTCA) for treatment of acute myocardial infarction, but were not successful. He was then treated with intracoronary streptokinase. Serial coronary angiographies showed recanalisation and aneurysm on the LAD. The patient was operated on with coronary bypass surgery, and treated with an oral anticoagulant, nitrate, and blocker. He was well after one year of follow-up.
Asunto(s)
Aneurisma Coronario/complicaciones , Infarto del Miocardio/etiología , Anciano , Angioplastia Coronaria con Balón , Aneurisma Coronario/diagnóstico por imagen , Aneurisma Coronario/cirugía , Angiografía Coronaria , Puente de Arteria Coronaria , Humanos , Masculino , Infarto del Miocardio/terapia , Terapia TrombolíticaRESUMEN
AIM: The aim of this study was to investigate iron status and its relationships with lipid peroxidation in patients with acute myocardial infarction (MI). METHODS: The study included 30 male patients aged between 32 and 73 years (mean 55 +/- 6) with acute MI. We measured the levels of plasma iron, transferrin (TF), ferritin (FER), ceruloplasmin (CER), cardiac enzymes, and erythrocyte malondialdehyde (e-MDA) in patients with acute MI on the admission and 1st, 3rd, 5th, 7th, 15th, 45th post MI day and investigated the variations of these parameters in acute MI. RESULTS: The e-MDA level started to increase on the admission day and showed a peak value on the post MI 1st day (88 +/- 23 and 98 +/- 26 nmol/g Hb, respectively). Afterwards, the e-MDA level minimally changed until post Ml 45th day, which showed a minimum level (57 +/- 13 nmol/g Hb) (p < 0.05). In addition, the iron concentration of serum reached its maximum level on the 1st post Ml day (99 +/- 30 mg/dl, p < 0.05) and relatively decreased after the 3rd day. Courses of MDA and iron levels were similar. The FER level started to increase from the admission day of the patients (230 +/- 375 mg/dl), showed a mean peak value on the 3rd day (296 +/- 568 mg/dl) and decreased to a minimum level on the 45th day (121 +/- 85 mg/dl) (p < 0.05). Contrarily, the TF level started to decrease on the 1st day (221 +/- 44 mg/dl), decreased minimum level on the 3rd day (211 +/- 37 mg/dl) and continued approximately the same level until the 45th day (244 +/- 45 mg/dl) (p < 0.05). The CER level started to increase from the first day of admission of the patients (43 +/- 12 mg/dl), reached a maximum level on the 7th day (59 +/- 12 mg/dl) and similar levels were observed until the 15th day. On the 45th day, the CER level was higher than on the first day (52 +/- 13 mg/dl) (p < 0.05). CONCLUSION: There was an association of higher iron status with increased lipid peroxidation in patients with myocardial infarction.